Medtronic Acquires New Diabetes Technology Medtronic, Inc. announced at its annual institutional investor and analyst meeting that the company purchased substantially all glucose monitoring assets from PreciSense A/S, a Denmark-based development company focused on continuous glucose monitoring technology. Specific terms of the acquisition were not disclosed. [more...]
